Powder: -20°C for 3 years | In solvent: -80°C for 1 year
S-8510 phosphate is an agonist of inverse Benzodiazepine (BDZ) receptor(Kis of 34.6 nM, 36.2 nM for –GABA and +GABA respectively).
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
25 mg | 10-14 weeks | $ 2,270.00 | |
50 mg | 10-14 weeks | $ 2,980.00 | |
100 mg | 10-14 weeks | $ 4,000.00 |
Description | S-8510 phosphate is an agonist of inverse Benzodiazepine (BDZ) receptor(Kis of 34.6 nM, 36.2 nM for –GABA and +GABA respectively). |
Targets&IC50 | GABA:ki: 34.6 nM , GABA+:36.2 nM (ki) |
In vitro | S-8510 has a relatively high affinity to BDZ receptors. The GABA ratio for S-8510 or CGS8216 is close to the value for flumazenil which is considered as an antagonist or a very weak agonist. S-8510 (10-7 M) enhances LTP and this enhancement is antagonized by BDZ receptor antagonist, flumazenil. Flumazenil itself does not atfect LTP or evokes responses prior to tetanic stimulation. S-8510 increases the amplitude of the population spike at a dose of 10-4 M, and this effect is completely antagonized by concomitant application of flumazenil (10-4 M) . |
In vivo | S-8510 or CGS8216, in combination with PTZ doses exceeding 90 mg/kg, can induce lethal convulsions, specifically enhancing PTZ-induced subconvulsive states. Moreover, scopolamine impairs memory by reducing time spent near a platform, an effect both S-8510 and CGS8216 reverse, thereby mitigating scopolamine-induced amnesia. Additionally, S-8510 counters diazepam-induced memory impairments in both water maze and passive avoidance paradigms and elevates ACh levels up to 100 mg/kg in a dose-dependent manner. It, along with PTZ, also increases extracellular NA levels in the hippocampus. The anxiogenic effects of S-8510, CGS8216, and FG7142 were assessed in Wistar rats using the water lick conflict paradigm. In ddY mice, S-8510 significantly reduces immobility in the forced swimming test at doses ranging from 40 to 80 mg/kg, indicating a dose-dependent improvement in depressive symptoms. For tetrabenazine-induced ptosis, S-8510 effectively lessens ptosis at doses above 10 mg/kg, though at its maximum, it reduces ptosis by only 39%, in contrast to imipramine's more potent reduction of about 80% at 20 mg/kg. |
Synonyms | SB-737552 phosphate |
Molecular Weight | 340.23 |
Formula | C12H13N4O6P |
CAS No. | 151466-23-8 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
S-8510 phosphate 151466-23-8 Others S 8510 phosphate SB-737552 phosphate SB 737552 Phosphate SB-737552 Phosphate S 8510 Phosphate S-8510 Phosphate S8510 phosphate S8510 Phosphate SB737552 Phosphate inhibitor inhibit